Connect
MJA
MJA

Population-based genetic carrier screening for cystic fibrosis in Victoria

Alison D Archibald, John Massie, Melanie J Smith, Deborah G Dalton, Desirée du Sart and David J Amor
Med J Aust 2014; 200 (4): 205-206. || doi: 10.5694/mja13.10864
Published online: 3 March 2014

To the Editor: Cystic fibrosis (CF) is the most common inherited life-shortening condition affecting Australian children, with a carrier frequency of 1 in 25. Most children with CF (94%) have no family history of the condition.1 The Human Genetics Society of Australasia recommends that couples planning or in the early stages of pregnancy be made aware of the availability of CF carrier screening.2 In Victoria, since 2006, CF carrier screening has been available to individuals and couples as a fee-for-service program.3 The program initially screened for 12 mutations (2006–2012) and now screens for 38 mutations (2012–2013) at a cost of $150 per patient. The program was established through collaboration between Victorian Clinical Genetics Services, the CF clinic at the Royal Children’s Hospital in Melbourne, obstetricians and Cystic Fibrosis Victoria.

  • Alison D Archibald1
  • John Massie2
  • Melanie J Smith1
  • Deborah G Dalton1
  • Desirée du Sart1
  • David J Amor1

  • 1 Victorian Clinical Genetics Services, Murdoch Childrens Research Institute, Melbourne, VIC.
  • 2 Royal Children’s Hospital, Melbourne, VIC.

Correspondence: david.amor@mcri.edu.au

Acknowledgements: 

This work was supported by the Victorian Government Operational Infrastructure Support Program.

Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.